Company name Total direct research and grant payments, $ (%) Total associated research payments, $ (%) Total research and grant payments, $ (%)
Gilead Sciences Inc 1,781,302 (4.9) 241,799,108 (16.2) 243,580,410 (16.0)
AbbVie, Inc 1,701,140 (4.7) 222,508,752 (14.9) 224,209,892 (14.7)
Pfizer Inc 2,719,827 (7.6) 115,172,458 (7.7) 117,892,285 (7.7)
Intercept Pharmaceuticals, Inc 633,830 (1.8) 84,121,144 (5.6) 84,754,974 (5.5)
Janssen Research & Development, LLC 298,339 (0.8) 83,034,668 (5.6) 83,333,007 (5.5)
Allergan Inc 383,504 (1.1) 68,615,842 (4.6) 68,999,345 (4.5)
Merck Sharp & Dohme Corporation 122,994 (0.3) 66,068,174 (4.4) 66,191,168 (4.3)
E.R. Squibb & Sons, LLC 687,954 (1.9) 54,952,751 (3.7) 55,640,705 (3.6)
Takeda Pharmaceuticals U.S.A., Inc 569,071 (1.6) 51,034,542 (3.4) 51,603,613 (3.4)
Shire North American Group Inc 5,381 (0.01) 41,687,210 (2.8) 41,692,592 (2.7)